Search

Home > GRACEcast Lung Cancer Video > Are EGFR TKIs (Such as Tarceva) Effective in Lung Cancer Patients Who Are Wild Type EGFR?
Podcast: GRACEcast Lung Cancer Video
Episode:

Are EGFR TKIs (Such as Tarceva) Effective in Lung Cancer Patients Who Are Wild Type EGFR?
Category: Science & Medicine
Duration: 00:01:02
Publish Date: 2014-09-25 14:00:00
Description:

For patients with wild type EGFR, meaning there is no EGFR mutation, drugs like Tarceva (erlotinib) can have a small benefit, but Dr. Joan Schiller wants research to do better. February 2014
Total Play: 0